- Patent Title: Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19
-
Application No.: US17709727Application Date: 2022-03-31
-
Publication No.: US11648300B1Publication Date: 2023-05-16
- Inventor: Alexandre Vasilievich Ivachtchenko , Andrey Alexandrovich Ivashchenko , Alena Alexandrovna Ivachtchenko , Ilya Andreevich Ivachtchenko , Nikolay Filippovich Savchuk
- Applicant: ASAVI LLC , Alexandre Vasilievich Ivachtchenko , Alena Alexandrovna Ivachtchenko , Nikolay Filippovich Savchuk
- Applicant Address: US FL Hallandale
- Assignee: ASAVI LLC,Alexandre Vasilievich Ivachtchenko,Alena Alexandrovna Ivachtchenko,Nikolay Filippovich Savchuk
- Current Assignee: ASAVI LLC,Alexandre Vasilievich Ivachtchenko,Alena Alexandrovna Ivachtchenko,Nikolay Filippovich Savchuk
- Current Assignee Address: US FL Hallandale; US FL Hallandale; US FL Hallandale; US CA Rancho Santa Fe
- Agency: Strain & Strain PLLC
- Agent Paul D. Strain, Esq.
- Main IPC: A61K38/57
- IPC: A61K38/57 ; A61P31/14 ; A61K31/427 ; A61K31/403

Abstract:
The present application relates to the new the pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including viral and bacterial pneumonia and COVID-19, using aprotinin (APR), ribavirin and/or nirmatrelvir (NIMR), the pharmaceutical kit and the pharmaceutical composition for this pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including COVID-19.
Public/Granted literature
- US1708094A Pressure sulphur burner Public/Granted day:1929-04-09
Information query
IPC分类: